Navigation Links
Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
Date:9/3/2007

REINACH, Switzerland, September 3 /PRNewswire/ -- Nitec Pharma AG, today announced the appointments of Anders Harfstrand as Chief Executive Officer, and Andrea Buscaglia as Chief Financial Officer. Both executives bring with them a wealth of strategic knowledge and expertise which complement that of the existing management team. The appointments will enable Nitec to drive the commercialization of its late-stage product, Lodotra (R) and progress the development of its pipeline.

Dr. Harfstrand and Mr. Buscaglia will complete Nitec's management team. They will work alongside the company's co-founders Jochen Mattis, Executive VP of Marketing and Sales and Dr. Achim Schaffler, Executive VP of R&D and Technical operations.

"I am extremely pleased that Anders has joined the Nitec Pharma team" said Dr. Karl Nagler, Member of Nitec's board of directors and Principal at Atlas Venture. "He has tremendous worldwide operational experience and impressive expertise in sales, marketing and business development. With Anders joining Nitec's management Board, we expect continued strong performance from Nitec going forward."

Dr. Harfstrand added, "I look forward to working with Nitec's experienced team to make Lodotra (R) a great success in treating rheumatoid arthritis. We intend to establish Nitec as a reliable partner for patients, physicians and investors by developing leading products and delivering innovative and cost-effective solutions for chronic inflammatory diseases and pain."

Commenting on Mr. Buscaglia's appointment, Jochen Mattis stated, "Andrea will be a great asset to our management team. During his career, he has been involved in numerous financial transactions, including several IPOs, giving him the experience to give strategic input and direction to our business. We are convinced that Andrea`s expertise will support Nitec during this exciting phase in the company's development."

Dr. Harfstrand brings to Nitec Pharma almost 20 year
'/>"/>

SOURCE Nitec Pharma AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Promega and Benitec settle contract case
2. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
3. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
4. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
5. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. Germantown drug company hires pharma veteran James Davidson as COO
8. Deltanoid Pharmaceuticals begins phase II osteoporosis study
9. New angel capital centered on GenTel agreement with big pharma
10. The deconstruction of Big Pharma
11. Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 SoundConnect, ... collaboration company is dedicated to supporting business communication ... Julie Power, a carrier services ... collaboration solutions stays connected and productive at all ... increased movement of businesses to cloud communications services. ...
(Date:9/30/2014)... Whitehouse Laboratories is pleased to ... Parenteral Drug Association (PDA) to host a unique ... closure integrity testing. This lecture/laboratory course will examine the ... detailed in the recently proposed revision to USP 1207 ... will span container closure integrity testing (leak testing) critical ...
(Date:9/29/2014)... the forefront of diagnostics today, with imaging techniques ... scanning, and NMR (nuclear magnetic resonance) increasing steeply ... of image resolution and quality still limit these ... A solution is hyperpolarization, which involves injecting the ... by following the distribution and fate of specific ...
(Date:9/29/2014)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, ... its three Promissory Note holders, two of whom are ... in July 2014 for a total of $ 300,000 ... into 3,500,001 restricted common shares. Notes were repayable within ... and the coupon were convertible into common shares to ...
Breaking Biology Technology:SoundConnect Expands Carrier Services Division 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4A safer approach for diagnostic medical imaging 2A safer approach for diagnostic medical imaging 3Portage announces conversion of its debt into equity 2Portage announces conversion of its debt into equity 3
... On Wednesday, October,22, 2008, Wyeth (NYSE: WYE ) ... Company will hold a one-hour conference call with,research analysts ... Interested,investors and others may listen to the call live ... may be accessed by visiting our website,at http://www.wyeth.com ...
... BOCA RATON, Fla., Sept. 8 NovaVision today ... at the prestigious AdvaMed,2008: The MedTech Conference ... DC., During the presentation, which falls in ... appointed chief executive officer of,NovaVision, will address the ...
... 8 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) ... 2008 Small Cap Healthcare Conference will be webcast and,may ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ), A member of Human Genome ... Wednesday, September 10, 2008 at 10:15 am Eastern,Time., ...
Cached Biology Technology:NovaVision CEO Named Presenter at the AdvaMed 2008 Conference 2
(Date:9/30/2014)... Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich report that ... cells more sensitive to chemotherapeutic drugs. They have ... a new target for anti-tumor agents. , ... Professor Stephan Sieber of the Technische Universitt Mnchen ... a potential new weapon in the fight against ...
(Date:9/30/2014)... news release is available in German . ... in their behavioural response to risky situations such as ... for Ornithology now found in a long-term study on ... with both metabolic rate and ambient temperature. High metabolic ... behaviour, as in these scenarios birds were more likely ...
(Date:9/30/2014)... People who suffer from asthma may think there,s not ... besides properly taking medications and avoiding allergic triggers. ... Annals of Allergy, Asthma and Immunology , the scientific ... Immunology (ACAAI), asthma sufferers can learn lessons about managing ... in the Annals article improved her asthma once she ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Risky metabolism 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... the publication of several commentaries in the scientific journal ... embryos it is safe and proper to place in a uterus, ... faced by all patients anxiously caught between no pregnancies at all ... place it is often all too easy to think that the ...
... German . The Deutsche Forschungsgemeinschaft (DFG, German ... Research Units and two Humanities Centres for Advanced Studies. This ... its July meeting in Bonn. The aim of the research ... devote their time to current and urgent questions in their ...
... Reserve University School of Medicine has received a $2.1 million ... the National Institutes of Health (NIH), to expand basic research ... is an inherited disease that causes thick, sticky mucus to ... NIH grant was awarded to Mitchell Drumm, PhD, and Craig ...
Cached Biology News:IVF treatment and multiple births: Free-market patient rights versus government regulation 2IVF treatment and multiple births: Free-market patient rights versus government regulation 3From bone metastases to water supply 2From bone metastases to water supply 3From bone metastases to water supply 4From bone metastases to water supply 5From bone metastases to water supply 6CWRU receives $2.1 million NIH grant to expand cystic fibrosis research models 2
EML1 (K-16)...
Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
Bovine Aortic Smooth Muscle Cells (BAOSMC) (>500,000 cells)...
... adapter allows the Thermo-Fast® ... AB-1000) PCR plates to ... ABI PRISM® 3700 capillary ... for information on the ...
Biology Products: